Clusterin knockdown using the antisense oligonucleotide OGX‐011 re‐sensitizes docetaxel‐refractory prostate cancer PC‐3 cells to chemotherapy von Sowery, Richard D., Hadaschik, Boris A., So, Alan I., Zoubeidi, Amina, Fazli, Ladan, Hurtado‐Coll, Antonio, Gleave, Martin E.

Volltext

Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer von Hadaschik, Boris A., Ter Borg, Melanie G., Jackson, John, Sowery, Richard D., So, Alan I., Burt, Helen M., Gleave, Martin E.

Volltext

Targeting prostate cancer with HTI‐286, a synthetic analog of the marine sponge product hemiasterlin von Hadaschik, Boris A., Ettinger, Susan, Sowery, Richard D., Zoubeidi, Amina, Andersen, Raymond J., Roberge, Michel, Gleave, Martin E.

Volltext

Novel targets and approaches in advanced prostate cancer von Hadaschik, Boris A, Sowery, Richard D, Gleave, Martin E

Volltext

Therapeutic options in advanced prostate cancer: present and future von Sowery, Richard D, So, Alan I, Gleave, Martin E

Volltext

Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy cells to chemotherapy von SOWERY, Richard D, HADASCHIK, Boris A, SO, Alan I, ZOUBEIDI, Amina, FAZLI, Ladan, HURTADO-COLL, Antonio, CLEAVE, Martin E

Volltext

Novel Therapies in Advanced Prostate Cancer von Sowery, Richard D., So, Alan I., Gleave, Martin E.

Volltext

Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver von Sowery, Richard D, Jensen, Clara, Morrison, Kevin B, Horsman, Douglas E, Sorensen, Poul H.B, Webber, Eric M

Volltext